Laurus Labs kicks off bookbuilding for Rp13bn float
Indian pharmaceutical firm Laurus Labs has opened books for an IPO that could raise Rp13.3bn ($195.3m), set to be the year's last big listing in the country.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts